Precardioversion Heart Rhythm Monitoring Using Smartphone Photoplethysmography
JAMA Cardiology 10.1001/jamacardio.2026.1269June 03, 2026 at 11:00 AM EDT
Is daily ambulatory heart rhythm monitoring precardioversion using smartphone photoplethysmography more effective than standard of care in reducing the number of same-day cancellations in scheduled cardioversions?In this randomized clinical trial including 203 participants, daily heart rhythm monitoring initiated 1 to 2 weeks prior to scheduled cardioversion for atrial fibrillation using smartphone photoplethysmography and reminders of anticoagulation compliance was superior to standard of care in reducing same-day cancellations.The findings suggest that precardioversion rhythm monitoring using smartphone photoplethysmography could support the optimization of health care resources.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.